1. Predictive factors for mortality in patients with methicillin- resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
- Author
-
Gasch, O., Camoez, M., Dominguez, M. A., Padilla, B., Pintado, V., Almirante, B., Molina, J., Lopez-Medrano, F., Ruiz, E., Martinez, J. A., Bereciartua, E., Rodriguez-Lopez, F., Fernandez-Mazarrasa, C., Goenaga, M. A., Benito, N., Rodriguez-Baño, J., Espejo, E., and Pujol, M.
- Subjects
- *
METHICILLIN-resistant staphylococcus aureus , *STAPHYLOCOCCUS aureus infections , *STAPHYLOCOCCUS aureus , *DEATH rate , *HOSPITALS , *PATIENTS , *THERAPEUTICS - Abstract
Mortality related to methicillin-resistant Staphylococcus aureus ( MRSA) bloodstream infection ( BSI) remains high, despite changes in the epidemiology. To analyze the current predictive factors for mortality we conducted a prospective study in a large cohort of patients with MRSA- BSI from 21 Spanish hospitals. Epidemiology, clinical data, therapy and outcome were recorded. All MRSA strains were analysed, including susceptibility to antibiotics and molecular characterization. Vancomycin MICs ( V- MIC) were tested by the E-test and microdilution methods. Time until death was the dependent variable in a Cox regression analysis. Overall, 579 episodes were included. Acquisition was nosocomial in 59% and vascular catheter was the most frequent source (38%). A dominant PFGE genotype was found in 368 (67%) isolates, which belonged to Clonal Complex ( CC)5 and carried SCCmec IV and agr2. Microdilution V- MIC50 and V- MIC90 were 0.7 and 1.0 mg/L, respectively. Initial therapy was appropriate in 66% of episodes. Overall mortality was observed in 179 (32%) episodes. The Cox-regression analysis identified age >70 years ( HR 1.88), previous fatal disease ( HR 2.16), Pitt score >1 ( HR 3.45), high-risk source ( HR 1.85) and inappropriate initial treatment ( HR 1.39) as independent predictive factors for mortality. CC5 and CC22 ( HR 0.52 and 0.45) were associated with significantly lower mortality rates than CC8. V-MIC ≥1.5 did not have a significant impact on mortality, regardless of the method used to assess it. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF